Circulating sclerostin is associated with bone mineral density independent of HIV-serostatus release_s4ogz56oonhihh4vsqr2iutpai

by Ryan D. Ross, Anjali Sharma, Qiuhu Shi, Donald R. Hoover, Kathleen M. Weber, Phyllis C. Tien, Audrey L. French, Lena Al-Harthi, Michael T. Yin

Published in Bone Reports by Elsevier BV.

Volume 12p100279 (2020)

Abstract

Low bone mineral density (BMD) is commonly observed in people living with HIV (PLWH), however the cause for this BMD loss remains unclear. Sclerostin, a bone-derived antagonist to the Wnt/β-catenin-pathway, suppresses bone remodeling and is positively associated with BMD. The goal of the current study was to investigate associations between sclerostin and BMD in a cohort of HIV-seropositive and demographically-matched seronegative women. This cross-sectional analysis used a subset of early postmenopausal women enrolled in the Women's Interagency HIV Study (WIHS). BMD was assessed at the lumbar spine, total hip, femoral neck, and distal and ultradistal radius via dual energy x-ray absorptiometry (DXA). Circulating sclerostin was assessed via commercial ELISAs. Univariate and multivariate linear regression modeling tested associations between sclerostin and BMD after adjusting for a variety of BMD-modifying variables. HIV-seropositive women had significantly reduced BMD at all skeletal sites compared to HIV-seronegative women. There was no difference in sclerostin levels according to HIV-serostatus (0.25 vs 0.27 ng/mL in HIV-seronegative and HIV-seropositive, respectively, p = 0.71). Circulating sclerostin was positively associated with BMD at all sites in both univariate and multivariate models adjusting for HIV status, age, BMI, and race, although the coefficients of association were attenuated in HIV-seropositive women. The positive association between sclerostin and BMD among seropositive women remained statistically significant after adjusting for ART or tenofovir disoproxil fumarate (TDF) use. The current study suggests that circulating sclerostin is a biomarker for bone mass for both HIV seronegative and seropositive women using and not using ART. The lower coefficients of association between sclerostin and BMD by HIV status may suggest HIV-induced alternation in osteocyte function.
In text/plain format

Archived Files and Locations

application/pdf  715.7 kB
file_qyhmeh6u5vcahpbb4k2mq3zkzq
web.archive.org (webarchive)
pdf.sciencedirectassets.com (publisher)
Read Archived PDF
Archived
Type  article-journal
Stage   published
Date   2020-05-11
Language   en ?
Container Metadata
Open Access Publication
In DOAJ
In Keepers Registery
ISSN-L:  2352-1872
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
Catalog Record
Revision: d167ae3f-c8af-4ea5-b409-c36a87bd18cb
API URL: JSON